PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Jul-2025 Lentiviral Vector CDMO Market sees 8% CAGR as gene therapy pipeline and R&D investments grow by 2030 MediTech-Insights
24-Jul-2025 Positron Emission Tomography Market to grow at 5% CAGR driven by oncology and neurology uses by 2030 MediTech-Insights
24-Jul-2025 Viromed Medical AG enters into a distribution partnership with TriPart for the market launch of ViroCAP® and PulmoPlas® in Turkey Viromed Medical AG
24-Jul-2025 DEA Marijuana Rescheduling Judge Mulrooney Retires Amid Constitutional Crisis and MMJ Marijuana Research Lawsuit ACCESS Newswire
24-Jul-2025 Abivax announces temporary trading halt of its ordinary shares on Euronext Paris ABIVAX
24-Jul-2025 AlzeCure's Rights Issue Oversubscribed, And the Company Resolves on A Directed Share Issue Under the Framework of An Overallotment Option ACCESS Newswire
24-Jul-2025 AlzeCure's Rights Issue Oversubscribed According to Preliminary Results ACCESS Newswire
24-Jul-2025 Biovica Awarded 3 MSEK Contract - 4th from Leading Tier-1 Pharma Company ACCESS Newswire
24-Jul-2025 Genflow Biosciences PLC Announces Clinical Readiness Acceleration ACCESS Newswire
23-Jul-2025 Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants ACCESS Newswire
23-Jul-2025 Abivax Announces Launch of Public Offering ABIVAX
23-Jul-2025 AlzeCure's Rights Issue Oversubscribed According to Preliminary Results ACCESS Newswire
23-Jul-2025 ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025 ACCESS Newswire
23-Jul-2025 Champions Oncology Reports Record Annual Revenue of $57 Million ACCESS Newswire
23-Jul-2025 Psilocybin Alliance Announces Incorporation and Industry Milestones in Effort to Protect Oregon's Legal Psilocybin Program ACCESS Newswire
23-Jul-2025 Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies Mainz BioMed N.V.
23-Jul-2025 European Commission approves DARZALEX® (daratumumab) as the first licensed treatment for patients with high-risk smouldering multiple myeloma J&J
23-Jul-2025 Black Book Survey Highlights Growing Divide Over AI Regulation in U.S. Healthcare ACCESS Newswire
23-Jul-2025 European Commission approves IMBRUVICA® (ibrutinib) as the first targeted therapy for patients with previously untreated mantle cell lymphoma who would be eligible for autologous stem cell transplant J&J
23-Jul-2025 Paralign Health Launches to Transform Preventative Care for Medically Underserved Americans ACCESS Newswire